Panel recommends Serum Institute's name for phase 2, 3 human clinical trials of Oxford vaccine candidate

The recommendations of the committee at the Central Drugs Standard Control Organisation have been sent to the Drugs Controller General of India for approval.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2Ev3isW
via IFTTT